Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2020 Filed Feb 28, 2020 02:20 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 24,414 | $61.44 Strike: $61.44 | $1,499,996.16 |
DisclosureSEC source: 0001367644-20-000017 · wf-form4_158285639623403.xml · derivative · entry 4 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,735 Underlying: Common Stock · 24,414 shares Expires 2027-02-24 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:20 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000017 · wf-form4_158285639623403.xml · nonDerivative · entry 2 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,144 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the three year period 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:20 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 6,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000017 · wf-form4_158285639623403.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,040 F1 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:26 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 22,784 | $61.44 Strike: $61.44 | $1,399,848.96 |
DisclosureSEC source: 0001367644-20-000021 · wf-form4_158285675699451.xml · derivative · entry 5 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,105 Underlying: Common Stock · 22,784 shares Expires 2027-02-24 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:26 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 5,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000021 · wf-form4_158285675699451.xml · nonDerivative · entry 2 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,889 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:26 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 5,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000021 · wf-form4_158285675699451.xml · nonDerivative · entry 1 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,192 F1 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:23 UTC |
Havey AdamEVP, Business Operations
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 22,784 | $61.44 Strike: $61.44 | $1,399,848.96 |
DisclosureSEC source: 0001367644-20-000019 · wf-form4_158285658301395.xml · derivative · entry 6 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,105 Underlying: Common Stock · 22,784 shares Expires 2027-02-24 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:23 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 5,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000019 · wf-form4_158285658301395.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,634 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:23 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 5,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000019 · wf-form4_158285658301395.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,937 F1 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:21 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 14,648 | $61.44 Strike: $61.44 | $899,973.12 |
DisclosureSEC source: 0001367644-20-000018 · wf-form4_158285647946534.xml · derivative · entry 6 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,668 Underlying: Common Stock · 14,648 shares Expires 2027-02-24 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:21 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
GrantCommon Stock | 3,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000018 · wf-form4_158285647946534.xml · nonDerivative · entry 2 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,928 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:21 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
GrantCommon Stock | 3,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000018 · wf-form4_158285647946534.xml · nonDerivative · entry 1 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,266 F1 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:22 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,010 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-006083 · doc4.xml · derivative · entry 6 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,203 Underlying: Common Stock · 6,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: On February 26, 2019, Mr. El-Hibri was granted 18,029 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. F6 · derivative.expiration_date: On February 26, 2019, Mr. El-Hibri was granted 18,029 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:22 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
GrantRestricted Stock Unit · Derivative | 19,532 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-006083 · doc4.xml · derivative · entry 5 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,213 Underlying: Common Stock · 19,532 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 25, 2020, Mr. El-Hibri was granted restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. F5 · derivative.expiration_date: On February 25, 2020, Mr. El-Hibri was granted restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:22 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 39,061 | $0.00 Strike: $61.44 | $0.00 |
DisclosureSEC source: 0000899243-20-006083 · doc4.xml · derivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,061 Underlying: Common Stock · 39,061 shares Expires 2027-02-24 F4 · derivative.exercise_date: On February 25, 2020, Mr. El-Hibri was granted 39,061 stock options vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:22 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 6,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-006083 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,485,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:17 UTC |
Kramer RobertPresident and CEO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 66,731 | $61.44 Strike: $61.44 | $4,099,952.64 |
DisclosureSEC source: 0001367644-20-000015 · wf-form4_158285623669698.xml · derivative · entry 6 Kramer Robert · CIK 0001380956 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,928 Underlying: Common Stock · 66,731 shares Expires 2027-02-24 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:17 UTC |
Kramer RobertPresident and CEO
|
GrantCommon Stock | 16,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000015 · wf-form4_158285623669698.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,760 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:17 UTC |
Kramer RobertPresident and CEO
|
GrantCommon Stock | 16,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000015 · wf-form4_158285623669698.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,077 F1 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 01:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 18,567 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-005665 · doc4.xml · derivative · entry 8 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,567 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 01:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 18,567 | $64.90 | $1,204,998.30 |
DisclosureSEC source: 0000899243-20-005665 · doc4.xml · nonDerivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,018 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 01:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 18,567 | $25.62 | $475,686.54 |
DisclosureSEC source: 0000899243-20-005665 · doc4.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,497,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:28 UTC |
Hauer Jerome MDirector
|
SaleCommon Stock | 6,572 | $70.00 | $460,040.00 |
DisclosureSEC source: 0001367644-20-000012 · wf-form4_158266609423712.xml · nonDerivative · entry 1 Hauer Jerome M · CIK 0001294935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,752 F1 · security: Consists of restricted stock units granted under the Company's stock incentive plan, as amended and restated. F2 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hauer. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:30 UTC |
Richard RonaldDirector
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 5,152 | $18.64 Strike: $18.64 | $96,033.28 |
DisclosureSEC source: 0001367644-20-000013 · wf-form4_158266622472686.xml · derivative · entry 3 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,893 Underlying: Common Stock · 5,152 shares Expires 2021-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F3 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. The date herein represents the third anniversary date of the grant and the final vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:30 UTC |
Richard RonaldDirector
|
SaleCommon Stock | 5,152 | $65.00 | $334,880.00 |
DisclosureSEC source: 0001367644-20-000013 · wf-form4_158266622472686.xml · nonDerivative · entry 2 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,395 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:30 UTC |
Richard RonaldDirector
|
Exercise / conversionCommon Stock | 5,152 | $18.64 | $96,033.28 |
DisclosureSEC source: 0001367644-20-000013 · wf-form4_158266622472686.xml · nonDerivative · entry 1 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. Read SEC document |
| February 20, 2020 Filed Feb 25, 2020 01:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 4,751 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-005665 · doc4.xml · derivative · entry 7 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,567 Underlying: Common Stock · 4,751 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 20, 2020 Filed Feb 25, 2020 01:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 4,751 | $64.90 | $308,339.90 |
DisclosureSEC source: 0000899243-20-005665 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,018 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 20, 2020 Filed Feb 25, 2020 01:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 4,751 | $25.62 | $121,720.62 |
DisclosureSEC source: 0000899243-20-005665 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,483,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 02:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 15,614 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-005195 · doc4.xml · derivative · entry 8 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,318 Underlying: Common Stock · 15,614 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 02:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 15,614 | $63.90 | $997,734.60 |
DisclosureSEC source: 0000899243-20-005195 · doc4.xml · nonDerivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,018 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 02:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 15,614 | $25.62 | $400,030.68 |
DisclosureSEC source: 0000899243-20-005195 · doc4.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,494,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 4,386 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-005195 · doc4.xml · derivative · entry 7 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,932 Underlying: Common Stock · 4,386 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 4,386 | $63.90 | $280,265.40 |
DisclosureSEC source: 0000899243-20-005195 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,018 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 4,386 | $25.62 | $112,369.32 |
DisclosureSEC source: 0000899243-20-005195 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,483,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 13,720 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-004522 · doc4.xml · derivative · entry 8 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,318 Underlying: Common Stock · 13,720 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 13,720 | $62.90 | $862,988.00 |
DisclosureSEC source: 0000899243-20-004522 · doc4.xml · nonDerivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,018 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 13,720 | $25.62 | $351,506.40 |
DisclosureSEC source: 0000899243-20-004522 · doc4.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,492,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 6,280 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-004522 · doc4.xml · derivative · entry 7 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,038 Underlying: Common Stock · 6,280 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 6,280 | $62.90 | $395,012.00 |
DisclosureSEC source: 0000899243-20-004522 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,018 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 6,280 | $25.62 | $160,893.60 |
DisclosureSEC source: 0000899243-20-004522 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,485,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 23:31 UTC |
El-Hibri FuadDirector · Executive Chairman · 10% owner
|
SaleCommon Stock | 11,684 | $61.90 | $723,239.60 |
DisclosureSEC source: 0000899243-20-003714 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,419,018 Read SEC document |
| February 06, 2020 Filed Feb 13, 2020 23:33 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 11,684 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-004524 · doc4a.xml · derivative · entry 8 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,318 Underlying: Common Stock · 11,684 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on February 7, 2020, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 06, 2020 Filed Feb 13, 2020 23:33 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 11,684 | $25.62 | $299,344.08 |
DisclosureSEC source: 0000899243-20-004524 · doc4a.xml · nonDerivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on February 7, 2020, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F3 · balance_after: The number of shares of Common Stock directly beneficially owned by the Reporting Person reported on this amended Form 4 gives effect to the sale of Common Stock by the Reporting Person as reported on the Form 4 filed by the Reporting Person with the SEC on February 7, 2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:31 UTC |
El-Hibri FuadDirector · Executive Chairman · 10% owner
|
SaleCommon Stock | 48,316 | $60.66 | $2,930,848.56 |
DisclosureSEC source: 0000899243-20-003714 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430,702 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the "Exchange Act"). F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.90 to $61.90. Read SEC document |
| February 05, 2020 Filed Feb 13, 2020 23:33 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 8,316 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-004524 · doc4a.xml · derivative · entry 7 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,002 Underlying: Common Stock · 8,316 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on February 7, 2020, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 05, 2020 Filed Feb 13, 2020 23:33 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-004524 · doc4a.xml · derivative · entry 6 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,318 Underlying: Common Stock · 20,000 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on February 7, 2020, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 05, 2020 Filed Feb 13, 2020 23:33 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0000899243-20-004524 · doc4a.xml · derivative · entry 5 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,318 Underlying: Common Stock · 20,000 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on February 7, 2020, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F4 · derivative.exercise_date: The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. Read SEC document |
| February 05, 2020 Filed Feb 13, 2020 23:33 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 8,316 | $25.62 | $213,055.92 |
DisclosureSEC source: 0000899243-20-004524 · doc4a.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on February 7, 2020, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F3 · balance_after: The number of shares of Common Stock directly beneficially owned by the Reporting Person reported on this amended Form 4 gives effect to the sale of Common Stock by the Reporting Person as reported on the Form 4 filed by the Reporting Person with the SEC on February 7, 2020. Read SEC document |
| February 05, 2020 Filed Feb 13, 2020 23:33 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 20,000 | $25.62 | $512,400.00 |
DisclosureSEC source: 0000899243-20-004524 · doc4a.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,519,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on February 7, 2020, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.